Paloma Partners Management CO Acadia Pharmaceuticals Inc Transaction History

Paloma Partners Management CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $239,416 - $526,199	-9,569 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $392,711 - $543,423	9,569 New	9,569 $512,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $9.18 Million - $14.4 Million	-252,100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $9.9 Million - $13.3 Million	252,100 New	252,100 $12.2 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $344,446 - $510,086	-10,883 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $394,073 - $559,386	10,883 New	10,883 $466,000
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $570,454 - $1.13 Million	-25,673 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $393,035 - $473,934	-16,854 Reduced 39.63%	25,673 $686,000
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $231,861 - $392,601	14,339 Added 50.87%	42,527 $1.14 Million
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $403,652 - $646,068	28,188 New	28,188 $456,000
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $488,488 - $712,348	-18,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $536,718 - $698,334	18,200	18,200 $686,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.